T-cell acute lymphoblastic leukaemia: Recent molecular biology findings

British Journal of Haematology

Volumn 156, Issue 3, 2012, Pages 303-315

  Kraszewska, Monika D ^a   Dawidowska, Małgorzata ^a   Szczepański, Tomasz ^b,c   Witt, Michał ^a,d  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

Author keywords

DNA methylation; Gene expression profiling; Gene mutations; Ig TCR gene rearrangements; Paediatric T ALL

Indexed keywords

DNA; IMMUNOGLOBULIN; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BCL11B GENE; BLAST CELL; CANCER CLASSIFICATION; CDKN2A GENE; CHROMOSOME ABERRATION; CPG ISLAND; DIAGNOSTIC PROCEDURE; DNA METHYLATION; FBXW7 GENE; FLT3 GENE; GENE EXPRESSION PROFILING; GENE MUTATION; GENE REARRANGEMENT; HUMAN; IL7R GENE; IMMUNOGLOBULIN GENE; LEUKEMOGENESIS; LMO2 GENE; LYL1 GENE; MINIMAL RESIDUAL DISEASE; MOLECULAR BIOLOGY; NOTCH1 GENE; NRAS GENE; ONCOGENE; PATIENT CARE; PATIENT MONITORING; PHF6 GENE; PRIORITY JOURNAL; PROGNOSIS; PTPN2 GENE; RELIABILITY; T CELL LEUKEMIA; T LYMPHOCYTE RECEPTOR GENE; TAL1 GENE; TLX1 GENE; TLX3 GENE; WT1 GENE;

ANTIGENS, CD; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENE REARRANGEMENT, B-LYMPHOCYTE; GENE REARRANGEMENT, T-LYMPHOCYTE; GENES, IMMUNOGLOBULIN; GENES, NEOPLASM; HUMANS; MUTATION; NEOPLASM PROTEINS; NEOPLASM, RESIDUAL; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS;

EID: 84855771076     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08957.x     Document Type: Article

References (95)

1. Asnafi, V., Buzyn, A., Le Noir, S., Baleydier, F., Simon, A., Beldjord, K., Reman, O., Witz, F., Fagot, T., Tavernier, E., Turlure, P., Leguay, T., Huguet, F., Vernant, J.P., Daniel, F., Bene, M.C., Ifrah, N., Thomas, X., Dombret, H. & Macintyre, E. (2009) NOTCH1/FBXW7 mutation identifies a large subgroup with favourable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a GRAALL study. Blood, 113, 3918-3924.
2. Baker, L.A., Allis, C.D. & Wang, G.G. (2008) PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks. Mutation Research, 647, 3-12.
3. Ballerini, P., Blaise, A., Busson-Le Coniat, M., Su, X.Y., Zucman-Rossi, J., Adam, M., van den Akker, J., Perot, C., Pellegrino, B., Landman-Parker, J., Douay, L., Berger, R. & Bernard, O.A. (2002) HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood, 100, 991-997.
4. Basso, K., Mussolin, L., Lettieri, A., Brahmachary, M., Lim, W.K., Califano, A., Basso, G., Biondi, A., Cazzaniga, G. & Rosolen, A. (2011) T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses. Genes Chromosomes Cancer, 50, 1063-1075.
5. Begley, C.G., Aplan, P.D., Davey, M.P., Nakahara, K., Tchorz, K., Kurtzberg, J., Hershfield, M.S., Haynes, B.F., Cohen, D.I., Waldmann, T.A. & Kirsch, I.R. (1989) Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proceedings of the National Academy of Sciences of the United States of America, 86, 2031-2035.
6. Bene, M.C., Castoldi, G., Knapp, W., Ludwig, W.D., Matutes, E., Orfao, A. & van't Veer, M.B. (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia, 9, 1783-1786.
7. Bernard, O.A., Busson-LeConiat, M., Ballerini, P., Mauchauffe, M., Della Valle, V., Monni, R., Nguyen Khac, F., Mercher, T., Penard-Lacronique, V., Pasturaud, P., Gressin, L., Heilig, R., Daniel, M.T., Lessard, M. & Berger, R. (2001) A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia, 15, 1495-1504.
8. Boehm, T., Foroni, L., Kaneko, Y., Perutz, M.F. & Rabbitts, T.H. (1991) The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proceedings of the National Academy of Sciences of the United States of America, 88, 4367-4371.
9. Breit, T.M., Mol, E.J., Wolvers-Tettero, I.L., Ludwig, W.D., van Wering, E.R. & van Dongen, J.J. (1993) Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes. J Exp Med, 177, 965-977.
10. Breit, S., Stanulla, M., Flohr, T., Schrappe, M., Ludwig, W.D., Tolle, G., Happich, M., Muckenthaler, M.U. & Kulozik, A.E. (2006) Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. Blood, 108, 1151-1157.
11. Bruggemann, M., van der Velden, V.H., Raff, T., Droese, J., Ritgen, M., Pott, C., Wijkhuijs, A.J., Gokbuget, N., Hoelzer, D., van Wering, E.R., van Dongen, J.J. & Kneba, M. (2004) Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia. Leukemia, 18, 709-719.
12. Bruggemann, M., Schrauder, A., Raff, T., Pfeifer, H., Dworzak, M., Ottmann, O.G., Asnafi, V., Baruchel, A., Bassan, R., Benoit, Y., Biondi, A., Cave, H., Dombret, H., Fielding, A.K., Foa, R., Gokbuget, N., Goldstone, A.H., Goulden, N., Henze, G., Hoelzer, D., Janka-Schaub, G.E., Macintyre, E.A., Pieters, R., Rambaldi, A., Ribera, J.M., Schmiegelow, K., Spinelli, O., Stary, J., von Stackelberg, A., Kneba, M., Schrappe, M. & van Dongen, J.J. (2010) Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia, 24, 521-535.
13. Burkhardt, B. (2010) Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases? British Journal of Haematology, 149, 653-668.
14. Cayuela, J.M., Madani, A., Sanhes, L., Stern, M.H. & Sigaux, F. (1996) Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood, 87, 2180-2186.
15. Clappier, E., Collette, S., Grardel, N., Girard, S., Suarez, L., Brunie, G., Kaltenbach, S., Yakouben, K., Mazingue, F., Robert, A., Boutard, P., Plantaz, D., Rohrlich, P., van Vlierberghe, P., Preudhomme, C., Otten, J., Speleman, F., Dastugue, N., Suciu, S., Benoit, Y., Bertrand, Y. & Cave, H. (2010) NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia, 24, 2023-2031.
16. Cleary, M.L., Mellentin, J.D., Spies, J. & Smith, S.D. (1988) Chromosomal translocation involving the beta T cell receptor gene in acute leukemia. J Exp Med, 167, 682-687.
17. Coustan-Smith, E., Mullighan, C.G., Onciu, M., Behm, F.G., Raimondi, S.C., Pei, D., Cheng, C., Su, X., Rubnitz, J.E., Basso, G., Biondi, A., Pui, C.H., Downing, J.R. & Campana, D. (2009) Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol, 10, 147-156.
18. Dawidowska, M., Derwich, K., Szczepanski, T., Jolkowska, J., van der Velden, V.H., Wachowiak, J. & Witt, M. (2006) Pattern of immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangements in Polish pediatric acute lymphoblastic leukemia patients - implications for RQ-PCR-based assessment of minimal residual disease. Leukemia Research, 30, 1119-1125.
19. Dawidowska, M., Jolkowska, J., Szczepanski, T., Derwich, K., Wachowiak, J. & Witt, M. (2008) Implementation of the standard strategy for identification of Ig/TCR targets for minimal residual disease diagnostics in B-cell precursor ALL pediatric patients: Polish experience. Archivum Immunologiae et Therapiae Experimentalis (Warsz), 56, 409-418.
20. De Keersmaecker, K., Graux, C., Odero, M.D., Mentens, N., Somers, R., Maertens, J., Wlodarska, I., Vandenberghe, P., Hagemeijer, A., Marynen, P. & Cools, J. (2005) Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32). Blood, 105, 4849-4852.
21. De Keersmaecker, K., Real, P.J., Gatta, G.D., Palomero, T., Sulis, M.L., Tosello, V., Van Vlierberghe, P., Barnes, K., Castillo, M., Sole, X., Hadler, M., Lenz, J., Aplan, P.D., Kelliher, M., Kee, B.L., Pandolfi, P.P., Kappes, D., Gounari, F., Petrie, H., Van der Meulen, J., Speleman, F., Paietta, E., Racevskis, J., Wiernik, P.H., Rowe, J.M., Soulier, J., Avran, D., Cave, H., Dastugue, N., Raimondi, S., Meijerink, J.P., Cordon-Cardo, C., Califano, A. & Ferrando, A.A. (2010) The TLX1 oncogene drives aneuploidy in T cell transformation. Nature Medicine, 16, 1321-1327.
22. Dear, T.N., Sanchez-Garcia, I. & Rabbitts, T.H. (1993) The HOX11 gene encodes a DNA-binding nuclear transcription factor belonging to a distinct family of homeobox genes. Proceedings of the National Academy of Sciences of the United States of America, 90, 4431-4435.
23. Demarest, R.M., Ratti, F. & Capobianco, A.J. (2008) It's T-ALL about Notch. Oncogene, 27, 5082-5091.
24. Dibenedetto, S.P., Lo Nigro, L., Mayer, S.P., Rovera, G. & Schiliro, G. (1997) Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia. Blood, 90, 1226-1232.
25. Dik, W.A., Brahim, W., Braun, C., Asnafi, V., Dastugue, N., Bernard, O.A., van Dongen, J.J., Langerak, A.W., Macintyre, E.A. & Delabesse, E. (2005a) CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia, 19, 1948-1957.
26. Dik, W.A., Pike-Overzet, K., Weerkamp, F., de Ridder, D., de Haas, E.F., Baert, M.R., van der Spek, P., Koster, E.E., Reinders, M.J., van Dongen, J.J., Langerak, A.W. & Staal, F.J. (2005b) New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J Exp Med, 201, 1715-1723.
27. van Dongen, J.J., Szczepanski, T. & Adriaansen, H.J. (2002) Immunobiology of Leukemia. In: Leukemia (eds by E.S. Henderson, T.A. Lister & M. F Greaves), pp. 85-129. WB Saunders Company, Philadelphia.
28. van Dongen, J.J., Langerak, A.W., Bruggemann, M., Evans, P.A., Hummel, M., Lavender, F.L., Delabesse, E., Davi, F., Schuuring, E., Garcia-Sanz, R., van Krieken, J.H., Droese, J., Gonzalez, D., Bastard, C., White, H.E., Spaargaren, M., Gonzalez, M., Parreira, A., Smith, J.L., Morgan, G.J., Kneba, M. & Macintyre, E.A. (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia, 17, 2257-2317.
29. Droese, J., Langerak, A.W., Groenen, P.J., Bruggemann, M., Neumann, P., Wolvers-Tettero, I.L., van Altena, M.C., Kneba, M. & van Dongen, J.J. (2004) Validation of BIOMED-2 multiplex PCR tubes for detection of TCRB gene rearrangements in T-cell malignancies. Leukemia, 18, 1531-1538.
30. Dube, I.D., Kamel-Reid, S., Yuan, C.C., Lu, M., Wu, X., Corpus, G., Raimondi, S.C., Crist, W.M., Carroll, A.J., Minowada, J. & Baker J.B. (1991) A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14). Blood, 78, 2996-3003.
31. Ferrando, A.A., Neuberg, D.S., Staunton, J., Loh, M.L., Huard, C., Raimondi, S.C., Behm, F.G., Pui, C.H., Downing, J.R., Gilliland, D.G., Lander, E.S., Golub, T.R. & Look, A.T. (2002) Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell, 1, 75-87.
32. Finger, L.R., Kagan, J., Christopher, G., Kurtzberg, J., Hershfield, M.S., Nowell, P.C. & Croce, C.M. (1989) Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proceedings of the National Academy of Sciences of the United States of America, 86, 5039-5043.
33. Flohr, T., Schrauder, A., Cazzaniga, G., Panzer-Grumayer, R., van der Velden, V., Fischer, S., Stanulla, M., Basso, G., Niggli, F.K., Schafer, B.W., Sutton, R., Koehler, R., Zimmermann, M., Valsecchi, M.G., Gadner, H., Masera, G., Schrappe, M., van Dongen, J.J., Biondi, A. & Bartram, C.R. (2008) Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia, 22, 771-782.
34. Goel, A., Li, M.S., Nagasaka, T., Shin, S.K., Fuerst, F., Ricciardiello, L., Wasserman, L. & Boland, C.R. (2006) Association of JC virus T-antigen expression with the methylator phenotype in sporadic colorectal cancers. Gastroenterology, 130, 1950-1961.
35. Graux, C., Stevens-Kroef, M., Lafage, M., Dastugue, N., Harrison, C.J., Mugneret, F., Bahloula, K., Struski, S., Gregoire, M.J., Nadal, N., Lippert, E., Taviaux, S., Simons, A., Kuiper, R.P., Moorman, A.V., Barber, K., Bosly, A., Michaux, L., Vandenberghe, P., Lahortiga, I., De Keersmaecker, K., Wlodarska, I., Cools, J., Hagemeijer, A. & Poirel, H.A. (2009) Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia. Leukemia, 23, 125-133.
36. van Grotel, M., Meijerink, J.P., Beverloo, H.B., Langerak, A.W., Buys-Gladdines, J.G., Schneider, P., Poulsen, T.S., den Boer, M.L., Horstmann, M., Kamps, W.A., Veerman, A.J., van Wering, E.R., van Noesel, M.M. & Pieters, R. (2006) The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. Haematologica, 91, 1212-1221.
37. Gutierrez, A., Kentsis, A., Sanda, T., Holmfeldt, L., Chen, S.C., Zhang, J., Protopopov, A., Chin, L., Dahlberg, S.E., Neuberg, D.S., Silverman, L.B., Winter, S.S., Hunger, S.P., Sallan, S.E., Zha, S., Alt, F.W., Downing, J.R., Mullighan, C.G. & Look, A.T. (2011) The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia. Blood, 118, 4169-4173.
38. Hebert, J., Cayuela, J.M., Berkeley, J. & Sigaux, F. (1994) Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood, 84, 4038-4044.
39. Huang, X., Shen, Q., Chen, S., Yang, L., Weng, J., Du, X., Grabarczyk, P., Przybylski, G.K., Schmidt, C.A. & Li, Y. (2011) Gene expression profiles in BCL11B-siRNA treated malignant T cells. J Hematol Oncol, 4, 23, Doi:10.1186/1756-8722-4-23.
40. Jones, P.A. & Baylin, S.B. (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet, 3, 415-428.
41. Kastner, P., Chan, S., Vogel, W.K., Zhang, L.J., Topark-Ngarm, A., Golonzhka, O., Jost, B., Le Gras, S., Gross, M.K. & Leid, M. (2010) Bcl11b represses a mature T-cell gene expression program in immature CD4(+)CD8(+) thymocytes. European Journal of Immunology, 40, 2143-2154.
42. Kennedy, M.A., Gonzalez-Sarmiento, R., Kees, U.R., Lampert, F., Dear, N., Boehm, T. & Rabbitts, T.H. (1991) HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. Proceedings of the National Academy of Sciences of the United States of America, 88, 8900-8904.
43. Kiyoi, H., Towatari, M., Yokota, S., Hamaguchi, M., Ohno, R., Saito, H. & Naoe, T. (1998) Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia, 12, 1333-1337.
44. Kleppe, M., Lahortiga, I., El Chaar, T., De Keersmaecker, K., Mentens, N., Graux, C., Van Roosbroeck, K., Ferrando, A.A., Langerak, A.W., Meijerink, J.P., Sigaux, F., Haferlach, T., Wlodarska, I., Vandenberghe, P., Soulier, J. & Cools, J. (2010) Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia. Nature Genetics, 42, 530-535.
45. Kox, C., Zimmermann, M., Stanulla, M., Leible, S., Schrappe, M., Ludwig, W.D., Koehler, R., Tolle, G., Bandapalli, O.R., Breit, S., Muckenthaler, M.U. & Kulozik, A.E. (2010) The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function. Leukemia, 24, 2005-2013.
46. Kraszewska, M.D., Dawidowska, M., Larmonie, N.S., Kosmalska, M., Sedek, L., Szczepaniak, M., Grzeszczak, W., Langerak, A.W., Szczepanski, T. & Witt, M. (2011) DNA methylation pattern is altered in childhood T-cell acute lymphoblastic leukemia patients as compared with normal thymic subsets: insights into CpG island methylator phenotype in T-ALL. Leukemia, doi:.
47. Larson Gedman, A., Chen, Q., Kugel Desmoulin, S., Ge, Y., LaFiura, K., Haska, C.L., Cherian, C., Devidas, M., Linda, S.B., Taub, J.W. & Matherly, L.H. (2009) The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia, 23, 1417-1425.
48. Lee, S., Hwang, K.S., Lee, H.J., Kim, J.S. & Kang, G.H. (2004) Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Laboratory Investigation, 84, 884-893.
49. Lhakhang, T.W. & Chaudhry, M.A. (2011) Current approaches to micro-RNA analysis and target gene prediction. J Appl Genet. E-pub ahead of print, Doi: 10.1007/s13353-011-0060-2.
50. Mansur, M.B., Emerenciano, M., Splendore, A., Brewer, L., Hassan, R. & Pombo-de-Oliveira, M.S. (2010) T-cell lymphoblastic leukemia in early childhood presents NOTCH1 mutations and MLL rearrangements. Leukemia Research, 34, 483-486.
51. Mao, S., Neale, G.A. & Goorha, R.M. (1997) T-cell proto-oncogene rhombotin-2 is a complex transcription regulator containing multiple activation and repression domains. J Biol Chem, 272, 5594-5599.
52. Marshall, C.J., Hall, A. & Weiss, R.A. (1982) A transforming gene present in human sarcoma cell lines. Nature, 299, 171-173.
53. Mavrakis, K.J., Van Der Meulen, J., Wolfe, A.L., Liu, X., Mets, E., Taghon, T., Khan, A.A., Setti, M., Rondou, P., Vandenberghe, P., Delabesse, E., Benoit, Y., Socci, N.B., Leslie, C.S., Van Vlierberghe, P., Speleman, F. & Wendel, H.G. (2011) A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nature Genetics, 43, 673-678.
54. Meijerink, J.P. (2010) Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia. Best Pract Res Clin Haematol, 23, 307-318.
55. Meleshko, A.N., Lipay, N.V., Stasevich, I.V. & Potapnev, M.P. (2005) Rearrangements of IgH, TCRD and TCRG genes as clonality marker of childhood acute lymphoblastic leukemia. Exp Oncol, 27, 319-324.
56. Milano, J., McKay, J., Dagenais, C., Foster-Brown, L., Pognan, F., Gadient, R., Jacobs, R.T., Zacco, A., Greenberg, B. & Ciaccio, P.J. (2004) Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicological Sciences, 82, 341-358.
57. Nakao, M., Janssen, J.W., Erz, D., Seriu, T. & Bartram, C.R. (2000) Tandem duplication of the FLT3 gene in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual disease. Leukemia, 14, 522-524.
58. O'Neil, J., Grim, J., Strack, P., Rao, S., Tibbitts, D., Winter, C., Hardwick, J., Welcker, M., Meijerink, J.P., Pieters, R., Draetta, G., Sears, R., Clurman, B.E. & Look, A.T. (2007) FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med, 204, 1813-1824.
59. Park, M.J., Taki, T., Oda, M., Watanabe, T., Yumura-Yagi, K., Kobayashi, R., Suzuki, N., Hara, J., Horibe, K. & Hayashi, Y. (2009) FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma. British Journal of Haematology, 145, 198-206.
60. Pirot, N., Deleuze, V., El-Hajj, R., Dohet, C., Sablitzky, F., Couttet, P., Mathieu, D. & Pinet, V. (2010) LYL1 activity is required for the maturation of newly formed blood vessels in adulthood. Blood, 115, 5270-5279.
61. Pongers-Willemse, M.J., Seriu, T., Stolz, F., d'Aniello, E., Gameiro, P., Pisa, P., Gonzalez, M., Bartram, C.R., Panzer-Grumayer, E.R., Biondi, A., San Miguel, J.F. & van Dongen, J.J. (1999) Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia, 13, 110-118.
62. Przybylski, G.K., Dik, W.A., Wanzeck, J., Grabarczyk, P., Majunke, S., Martin-Subero, J.I., Siebert, R., Dolken, G., Ludwig, W.D., Verhaaf, B., van Dongen, J.J., Schmidt, C.A. & Langerak, A.W. (2005) Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia, 19, 201-208.
63. Pui, C.H., Robison, L.L. & Look, A.T. (2008) Acute lymphoblastic leukaemia. Lancet, 371, 1030-1043.
64. Real, P.J., Tosello, V., Palomero, T., Castillo, M., Hernando, E., de Stanchina, E., Sulis, M.L., Barnes, K., Sawai, C., Homminga, I., Meijerink, J., Aifantis, I., Basso, G., Cordon-Cardo, C., Ai, W. & Ferrando, A. (2009) Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nature Medicine, 15, 50-58.
65. Robbins, S.H., Walzer, T., Dembele, D., Thibault, C., Defays, A., Bessou, G., Xu, H., Vivier, E., Sellars, M., Pierre, P., Sharp, F.R., Chan, S., Kastner, P. & Dalod, M. (2008) Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biology, 9, R17.
66. Robertson, K.D. & Jones, P.A. (1999) Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus. Oncogene, 18, 3810-3820.
67. Roman-Gomez, J., Jimenez-Velasco, A., Agirre, X., Prosper, F., Heiniger, A. & Torres, A. (2005) Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. Journal of Clinical Oncology, 23, 7043-7049.
68. Roman-Gomez, J., Jimenez-Velasco, A., Barrios, M., Prosper, F., Heiniger, A., Torres, A. & Agirre, X. (2007) Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes. Leukaemia & Lymphoma, 48, 1269-1282.
69. Royer-Pokora, B., Loos, U. & Ludwig, W.D. (1991) TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene, 6, 1887-1893.
70. Schlissel, M.S. (2003) Regulating antigen-receptor gene assembly. Nature Reviews Immunology, 3, 890-899.
71. Schrappe, M., Valsecchi, M.G., Bartram, C.R., Schrauder, A., Panzer-Grumayer, R., Moricke, A., Parasole, R., Zimmermann, M., Dworzak, M., Buldini, B., Reiter, A., Basso, G., Klingebiel, T., Messina, C., Ratei, R., Cazzaniga, G., Kohler, R., Locatelli, F., Schafer, B.W., Arico, M., Welte, K., van Dongen, J.J., Gadner, H., Biondi, A. & Conter, V. (2011) Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood, 118, 2077-2084.
72. Soulier, J., Clappier, E., Cayuela, J.M., Regnault, A., Garcia-Peydro, M., Dombret, H., Baruchel, A., Toribio, M.L. & Sigaux, F. (2005) HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood, 106, 274-286.
73. Starkova, J., Zamostna, B., Mejstrikova, E., Krejci, R., Drabkin, H.A. & Trka, J. (2010) HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL. Pediatric Blood & Cancer, 55, 1072-1082.
74. Sudhakar, N., Nancy, N.K., Rajalekshmy, K.R., Ramanan, G. & Rajkumar, T. (2007) T-cell receptor gamma and delta gene rearrangements and junctional region characteristics in south Indian patients with T-cell acute lymphoblastic leukemia. American Journal of Hematology, 82, 215-221.
75. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pilieri, S.A., Stein, H., Thiele, J. & Vardiman, J.W., eds. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. IARC Press, Lyon.
76. Szczepanski, T. (2007) Why and how to quantify minimal residual disease in acute lymphoblastic leukemia? Leukemia, 21, 622-626.
77. Szczepanski, T., Beishuizen, A., Pongers-Willemse, M.J., Hahlen, K., Van Wering, E.R., Wijkhuijs, A.J., Tibbe, G.J., De Bruijn, M.A. & Van Dongen, J.J. (1999a) Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease. Leukemia, 13, 196-205.
78. Szczepanski, T., Pongers-Willemse, M.J., Langerak, A.W., Harts, W.A., Wijkhuijs, A.J., van Wering, E.R. & van Dongen, J.J. (1999b) Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage. Blood, 93, 4079-4085.
79. Szczepanski, T., Langerak, A.W., Willemse, M.J., Wolvers-Tettero, I.L., van Wering, E.R. & van Dongen, J.J. (2000) T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia refelct 'end-stage' recombinations: implications for minimal residual disease monitoring. Leukemia, 14, 1208-1214.
80. Szczepanski, T., Harrison, C.J. & van Dongen, J.J. (2010) Genetic aberrations in paediatric acute leukaemias and implications for management of patients. Lancet Oncol, 11, 880-889.
81. Szczepanski, T., van der Velden, V.H., Waanders, E., Kuiper, R.P., Van Vlierberghe, P., Gruhn, B., Eckert, C., Panzer-Grumayer, R., Basso, G., Cave, H., Stadt, U.Z., Campana, D., Schrauder, A., Sutton, R., van Wering, E., Meijerink, J.P. & van Dongen, J.J. (2011) Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition. Journal of Clinical Oncology, 29, 1643-1649.
82. Thompson, B.J., Buonamici, S., Sulis, M.L., Palomero, T., Vilimas, T., Basso, G., Ferrando, A. & Aifantis, I. (2007) The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med, 204, 1825-1835.
83. Thorn, I., Forestier, E., Botling, J., Thuresson, B., Wasslavik, C., Bjorklund, E., Li, A., Lindstrom-Eriksson, E., Malec, M., Gronlund, E., Torikka, K., Heldrup, J., Abrahamsson, J., Behrendtz, M., Soderhall, S., Jacobsson, S., Olofsson, T., Porwit, A., Lonnerholm, G., Rosenquist, R. & Sundstrom, C. (2011) Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry. British Journal of Haematology, 152, 743-753.
84. Tosello, V., Mansour, M.R., Barnes, K., Paganin, M., Sulis, M.L., Jenkinson, S., Allen, C.G., Gale, R.E., Linch, D.C., Palomero, T., Real, P., Murty, V., Yao, X., Richards, S.M., Goldstone, A., Rowe, J., Basso, G., Wiernik, P.H., Paietta, E., Pieters, R., Horstmann, M., Meijerink, J.P. & Ferrando, A.A. (2009) WT1 mutations in T-ALL. Blood, 114, 1038-1045.
85. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J.G., Baylin, S.B. & Issa, J.P. (1999) CpG island methylator phenotype in colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America, 96, 8681-8686.
86. Van Vlierberghe, P., Meijerink, J.P., Stam, R.W., van der Smissen, W., van Wering, E.R., Beverloo, H.B. & Pieters, R. (2005) Activating FLT3 mutations in CD4+/CD8- pediatric T-cell acute lymphoblastic leukemias. Blood, 106, 4414-4415.
87. Van Vlierberghe, P., Palomero, T., Khiabanian, H., Van der Meulen, J., Castillo, M., Van Roy, N., De Moerloose, B., Philippe, J., Gonzalez-Garcia, S., Toribio, M.L., Taghon, T., Zuurbier, L., Cauwelier, B., Harrison, C.J., Schwab, C., Pisecker, M., Strehl, S., Langerak, A.W., Gecz, J., Sonneveld, E., Pieters, R., Paietta, E., Rowe, J.M., Wiernik, P.H., Benoit, Y., Soulier, J., Poppe, B., Yao, X., Cordon-Cardo, C., Meijerink, J., Rabadan, R., Speleman, F. & Ferrando, A. (2010) PHF6 mutations in T-cell acute lymphoblastic leukemia. Nature Genetics, 42, 338-342.
88. van der Velden, V.H., Cazzaniga, G., Schrauder, A., Hancock, J., Bader, P., Panzer-Grumayer, E.R., Flohr, T., Sutton, R., Cave, H., Madsen, H.O., Cayuela, J.M., Trka, J., Eckert, C., Foroni, L., Zur Stadt, U., Beldjord, K., Raff, T., van der Schoot, C.E. & van Dongen, J.J. (2007) Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia, 21, 604-611.
89. Weng, A.P., Ferrando, A.A., Lee, W., Morris, J.P., Silverman, L.B., Sanchez-Irizarry, C., Blacklow, S.C., Look, A.T. & Aster, J.C. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science (New York, N.Y.), 306, 269-271.
90. Willemse, M.J., Seriu, T., Hettinger, K., d'Aniello, E., Hop, W.C., Panzer-Grumayer, E.R., Biondi, A., Schrappe, M., Kamps, W.A., Masera, G., Gadner, H., Riehm, H., Bartram, C.R. & van Dongen, J.J. (2002) Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL. Blood, 99, 4386-4393.
91. Wu, Y., Cain-Hom, C., Choy, L., Hagenbeek, T.J., de Leon, G.P., Chen, Y., Finkle, D., Venook, R., Wu, X., Ridgway, J., Schahin-Reed, D., Dow, G.J., Shelton, A., Stawicki, S., Watts, R.J., Zhang, J., Choy, R., Howard, P., Kadyk, L., Yan, M., Zha, J., Callahan, C.A., Hymowitz, S.G. & Siebel, C.W. (2010) Therapeutic antibody targeting of individual Notch receptors. Nature, 464, 1052-1057.
92. Yamada, Y., Jackson-Grusby, L., Linhart, H., Meissner, A., Eden, A., Lin, H. & Jaenisch, R. (2005) Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America, 102, 13580-13585.
93. Yokota, S., Nakao, M., Horiike, S., Seriu, T., Iwai, T., Kaneko, H., Azuma, H., Oka, T., Takeda, T., Watanabe, A., Kikuta, A., Asami, K., Sekine, I., Matsushita, T., Tsuhciya, T., Mimaya, J., Koizumi, S., Miyake, M., Nishikawa, K., Takaue, Y., Kawano, Y., Iwai, A., Ishida, Y., Matsumoto, K. & Fujimoto, T. (1998) Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: a study of 125 Japanese pediatric cases. International Journal of Hematology, 67, 379-387.
94. Zenatti, P.P., Ribeiro, D., Li, W., Zuurbier, L., Silva, M.C., Paganin, M., Tritapoe, J., Hixon, J.A., Silveira, A.B., Cardoso, B.A., Sarmento, L.M., Correia, N., Toribio, M.L., Kobarg, J., Horstmann, M., Pieters, R., Brandalise, S.R., Ferrando, A.A., Meijerink, J.P., Durum, S.K., Yunes, J.A. & Barata, J.T. (2011) Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Nature Genetics, 43, 932-939.
95. Zuurbier, L., Homminga, I., Calvert, V., te Winkel, M.L., Buijs-Gladdines, J.G., Kooi, C., Smits, W.K., Sonneveld, E., Veerman, A.J., Kamps, W.A., Horstmann, M., Petricoin, E.F. IIIrd, Pieters, R. & Meijerink, J.P. (2010) NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols. Leukemia, 24, 2014-2022.